Clinical Trials Logo

Perforated Appendicitis clinical trials

View clinical trials related to Perforated Appendicitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04512196 Completed - Clinical trials for Perforated Appendicitis

Surgical Site Infection in Perforated Appendicitis After Peritoneal Lavage With Super-oxidised Solution

PLaSSo
Start date: September 9, 2020
Phase: N/A
Study type: Interventional

This study is to evaluate the effectiveness of peritoneal lavage with super-oxidised solution in reducing surgical site infection after open surgery for perforated appendicitis.

NCT ID: NCT04472052 Completed - Covid19 Clinical Trials

Frequency of Perforated Appendicitis in Times of COVID-19

Start date: March 16, 2020
Phase:
Study type: Observational

Appendicitis is one of the most common clinical conditions in general surgery. The diagnosis is usually made from clinical examination, imaging (sonography or CT) and laboratory parameters. The laparoscopic appendectomy without drainage has established as the gold standard. Patients usually leave the hospital two days after surgery. In times of corona crisis, patients are unsure to visit the hospital because of fear of infection with SARS-CoV-2. A higher incidence of perforated appendicitis could be an indicator for fear-related delay of going to the hospital. Methods: Investigators performed a retrospective analysis on the incidence of perforated appendicitis in a 10-week interval (mid-March to end of May) of the years 2018, 2019 and 2020 to evaluate possible changes in times of corona crisis. Intraoperative findings, procedures, complications and the length of hospital stay were considered.

NCT ID: NCT03289351 Completed - Clinical trials for Postoperative Infection

Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis

Start date: May 22, 2017
Phase: Phase 4
Study type: Interventional

After appendix has been removed for perforated appendicitis, patients will receive postoperative antibiotics. In the last 5 years, the literature has transitioned from a 3 -drug therapy to 2-drug therapy. Now there is a recent literature suggesting a single-drug therapy may be safe and adequate. In fact, using zosyn (piperacillin-tazobactam) as a single-drug therapy, there are additional benefits of simplicity, compliance, and lower infectious complications. Currently surgeons are already using both 2-drug regimen (ceftriaxone/metronidazole) and single-drug regimen (zosyn) interchangeable as both are FDA approved and regulated antibiotics for intra-abdominal infection. There is a clear need to compare outcomes between these two options.

NCT ID: NCT03159754 Completed - Appendicitis Clinical Trials

Optimal Care of Complicated Appendicitis

Start date: June 29, 2017
Phase: Phase 4
Study type: Interventional

When the appendix becomes infected and inflamed, it is called appendicitis. Sometimes, if the infection and inflammation get worse, the appendix can die or burst, leading to a larger infection or even pus pockets around the appendix. This is called complicated, or perforated, appendicitis. Three common treatments for complicated appendicitis are - appendectomy (removal of the appendix) right away - appendectomy several weeks after the diagnosis - treating the appendicitis without performing an appendectomy This study seeks to determine which of these three approaches is most cost-effective in children with complicated appendicitis.

NCT ID: NCT02881996 Completed - Clinical trials for Perforated Appendicitis

The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis

Start date: June 2014
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate two standard post-operative pain regimens routinely used after laparoscopic appendectomy for perforated appendicitis. The investigators hypothesize that the use of intravenous (IV) acetaminophen in addition to IV ketorolac with narcotic pain pump will decrease time to transition off patient/nurse controlled analgesia (PCA) to oral pain medications.

NCT ID: NCT02724410 Completed - Clinical trials for Perforated Appendicitis

Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis

Start date: January 2011
Phase: N/A
Study type: Interventional

To compare the effect of a single-agent home intravenous (IV) versus oral antibiotic therapy on complication rates and resource utilization following appendectomy for perforated appendicitis

NCT ID: NCT00854815 Completed - Clinical trials for Perforated Appendicitis

Irrigation Versus No Irrigation for Perforated Appendicitis

Start date: December 2008
Phase: N/A
Study type: Interventional

The purpose is to quantify the effect of irrigation during laparoscopic appendectomy for perforated appendicitis.

NCT ID: NCT00677417 Completed - Clinical trials for Perforated Appendicitis

Diagnostic Value of Hyperbilirubinaemia as a Predictive Factor for Appendiceal Perforation in Acute Appendicitis

Start date: May 2008
Phase: N/A
Study type: Observational

The values of laboratory examinations which are useful for the diagnoses of appendicitis are white blood cell count (WBC), C-reactive protein (CRP) and erythrocyte blood sedimentation rate (ESR). However up to date there is no laboratory marker for the pre-operative diagnosis of appendiceal perforation in acute appendicitis. Recently hyperbilirubinaemia has been associated with appendiceal perforation. Aim of this retrospective study is therefore to investigate if hyperbilirubinaemia has a diagnostic value for the pre-operative diagnosis of appendiceal perforation in patients with appendicitis.

NCT ID: NCT00528138 Completed - Clinical trials for Perforated Appendicitis

Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation

Start date: October 2007
Phase: N/A
Study type: Observational

It has recently been published that hyperbilirubinemia is a reliable marker for the preoperative diagnosis of perforated acute appendicitis. The investigators believe, based on their own previous publications, that C-reactive protein (CRP) with or without a white blood cell count and some other clinical parameters, are more specific markers for the preoperative diagnosis of perforated acute appendicitis. The purpose of this study is to prospectively compare the specificity and sensitivity of hyperbilirubinemia CRP, white blood cell count and other clinical parameters for the preoperative diagnosis of acute appendicitis.

NCT ID: NCT00462020 Completed - Clinical trials for Perforated Appendicitis

Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis

Start date: March 2007
Phase: N/A
Study type: Interventional

The objective of this study is to scientifically evaluate two different management strategies for perforated appendicitis. The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic decrease in medical care expenses for the patient. The primary outcome variable between the two strategies is abscess rate.